Category: Bristol kidney cancer drug cut death risk 37 pct in key patients

Bristol kidney cancer drug cut death risk 37 pct in key patients

  1. Bristol kidney cancer drug cut death risk 37 pct in key patients  Reuters
  2. #ESMO17: Bristol-Myers posts data on an upset checkpoint combo victory in frontline kidney cancer  Endpoints News
  3. Full coverage

from Business – Google News https://in.reuters.com/article/health-cancer-bristol-myers/bristol-kidney-cancer-drug-cut-death-risk-37-pct-in-key-patients-idINL5N1LR0GW

Advertisements

Bristol kidney cancer drug cut death risk 37 pct in key patients

  1. Bristol kidney cancer drug cut death risk 37 pct in key patients  Reuters
  2. Bristol-Myers posts data on an upset checkpoint combo victory in frontline kidney cancer  Endpoints News
  3. Full coverage

from Business – Google News https://in.reuters.com/article/health-cancer-bristol-myers/bristol-kidney-cancer-drug-cut-death-risk-37-pct-in-key-patients-idINL5N1LR0GW